198 related articles for article (PubMed ID: 35505651)
1. The prognostic role of diabetes mellitus type 2 in the setting of hepatocellular carcinoma: a systematic review and meta-analysis.
Mrzljak A; Cigrovski Berković M; Giovanardi F; Lai Q
Croat Med J; 2022 Apr; 63(2):176-186. PubMed ID: 35505651
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
3. The effect of metformin usage on survival outcomes for hepatocellular carcinoma patients with type 2 diabetes mellitus after curative therapy.
Yuan B; Ma J; Wang J; Hao J
Front Endocrinol (Lausanne); 2022; 13():1060768. PubMed ID: 36583006
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of metformin in diabetes mellitus type 2 patients with hepatocellular carcinoma: A systematic review and meta-analysis.
Cigrovski Berkovic M; Giovanardi F; Mrzljak A; Lai Q
World J Diabetes; 2023 Aug; 14(8):1289-1300. PubMed ID: 37664473
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis.
Wang YG; Wang P; Wang B; Fu ZJ; Zhao WJ; Yan SL
PLoS One; 2014; 9(5):e95485. PubMed ID: 24830459
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes.
Zhou J; Ke Y; Lei X; Wu T; Li Y; Bao T; Tang H; Zhang C; Wu X; Wang G; Li J; Zhang H; Ni F; Ye Z; Wang L
Ann Hepatol; 2020; 19(3):320-328. PubMed ID: 31980358
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
Schoppmeyer K; Weis S; Mössner J; Fleig WE
Cochrane Database Syst Rev; 2009 Jul; (3):CD006745. PubMed ID: 19588401
[TBL] [Abstract][Full Text] [Related]
8. Role of vitamin K2 in preventing the recurrence of hepatocellular carcinoma after curative treatment: a meta-analysis of randomized controlled trials.
Riaz IB; Riaz H; Riaz T; Rahman S; Amir M; Badshah MB; Kazi AN
BMC Gastroenterol; 2012 Nov; 12():170. PubMed ID: 23191943
[TBL] [Abstract][Full Text] [Related]
9. Association of Metformin Use With Cancer-Specific Mortality in Hepatocellular Carcinoma After Curative Resection: A Nationwide Population-Based Study.
Seo YS; Kim YJ; Kim MS; Suh KS; Kim SB; Han CJ; Kim YJ; Jang WI; Kang SH; Tchoe HJ; Park CM; Jo AJ; Kim HJ; Choi JA; Choi HJ; Polak MN; Ko MJ
Medicine (Baltimore); 2016 Apr; 95(17):e3527. PubMed ID: 27124061
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of diabetes mellitus in hepatocellular carcinoma patients after curative treatments: a meta-analysis.
Wang WM; Xu Y; Yang XR; Wang YH; Sun HX; Fan J
Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):346-55. PubMed ID: 21813381
[TBL] [Abstract][Full Text] [Related]
11. Association of liver cirrhosis severity with type 2 diabetes mellitus in hepatocellular carcinoma.
Makol A; Kanthaje S; Dhiman RK; Kalra N; Chawla YK; Chakraborti A
Exp Biol Med (Maywood); 2018 Feb; 243(4):323-326. PubMed ID: 29186978
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis.
Zhang G; Yu X; Liu P; Huang X; Jiang X
Dig Dis Sci; 2018 Dec; 63(12):3207-3219. PubMed ID: 30140982
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of PIVKA-II in hepatocellular carcinoma patients receiving curative ablation: A systematic review and meta-analysis.
Zhang D; Liu Z; Yin X; Qi X; Lu B; Liu Y; Hou J
Int J Biol Markers; 2018 Aug; 33(3):266-274. PubMed ID: 29658364
[TBL] [Abstract][Full Text] [Related]
14. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.
Yang WS; Va P; Bray F; Gao S; Gao J; Li HL; Xiang YB
PLoS One; 2011; 6(12):e27326. PubMed ID: 22205924
[TBL] [Abstract][Full Text] [Related]
15. Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy.
Hosokawa T; Kurosaki M; Tsuchiya K; Matsuda S; Muraoka M; Suzuki Y; Tamaki N; Yasui Y; Nakata T; Nishimura T; Suzuki S; Ueda K; Nakanishi H; Itakura J; Takahashi Y; Izumi N
World J Gastroenterol; 2013 Jan; 19(2):249-57. PubMed ID: 23345948
[TBL] [Abstract][Full Text] [Related]
16. The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma.
Lai Q; De Matthaeis N; Finotti M; Galati G; Marrone G; Melandro F; Morisco F; Nicolini D; Pravisani R; Giannini EG;
Eur J Clin Invest; 2023 Jan; 53(1):e13870. PubMed ID: 36075611
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis.
Dong W; Zhang T; Wang ZG; Liu H
World J Gastroenterol; 2014 Aug; 20(29):10174-82. PubMed ID: 25110446
[TBL] [Abstract][Full Text] [Related]
18. Comparison of nucleoside and nucleotide analogs in the recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection: A multicenter study.
Qi W; Shen J; Dai J; Wu Y; Zhang Y; Leng S; Gao F; Ran S; Peng W; Zhang X; Wen T; Li C
Cancer Med; 2021 Dec; 10(23):8421-8431. PubMed ID: 34643050
[TBL] [Abstract][Full Text] [Related]
19. AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.
Singal AG; Lim JK; Kanwal F
Gastroenterology; 2019 Jun; 156(8):2149-2157. PubMed ID: 30878469
[TBL] [Abstract][Full Text] [Related]
20. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
Qi X; Liu L; Wang D; Li H; Su C; Guo X
Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
